Form D · Other

Humalytix Inc.

Mansfield, GA · CIK 0001982146

Offering snapshot reported Aug 28, 2023 · SEC filing

Reported sold
$35M
Offering amount: $35M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 4, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 28, 2023Initial$34,999,982No comparison8SEC filing
Jun 20, 2023Initial$2,562,496No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-490778

Source: Form D, filed Aug 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Abbott Director, Executive
Brad Fielder Director
Kris Snyder Director
Jack Tankersley Director
Rob Toomey Director

Issuer details

Industry: Other (See others in industry)

Address:
1940 Macedonia Road
Mansfield, GA, 30055